Print
V526-001 MRKAd5 and MRKAd6 HIV-1 Trigene Vaccines
NCT00850616
Trial Details:
Phase:
I
Status:
Completed
Organizer developer:
Merck
Start Date:
Product:
MRKAd5 HIV-1 gag/pol/nef,MRKAd5+6 HIV-1,MRKAd6
Antigen:
Prime 1:
Prime Class:
Boost 1:
RandD/trials/Lists/ClinicalTrialsList
Boost 1 class:
Boost 2:
Boost 2 Class:
Boost 3:
Boost 3 Class:
Adjuvant:
Country:
Volunteers:
Ad5 Gag,pol,nef; Ad5 & Ad6 Nef, gag, pol B; Ad6 Gag,pol,nef B
ClinicalTrials.gov Identifier:
Link: